Complications of antipsychotic therapy in children with tourette syndrome

Tamara Pringsheim1, Michelle Pearce

  • 1Department of Clinical Neurosciences and Pediatrics, University of Calgary, Calgary, Alberta, Canada. tmprings@ucalgary.ca

Pediatric Neurology
|August 5, 2010
PubMed

Insights

Antipsychotics effectively manage Tourette syndrome tics but frequently cause metabolic side effects like lipid abnormalities and abnormal BMI in children. Neurologic complications were rare, suggesting atypical antipsychotics may be safer.

Area of Science:

  • Pediatric Neurology
  • Metabolic Disorders
  • Pharmacology

Background:

  • Antipsychotics are crucial for managing Tourette syndrome tics.
  • These medications can lead to significant metabolic and neurologic side effects in children.

Purpose of the Study:

  • To systematically monitor metabolic and neurologic side effects in children with Tourette syndrome treated with antipsychotics.
  • To assess the incidence and nature of these adverse events over time.

Main Methods:

  • A single-center study followed 73 children with Tourette syndrome requiring antipsychotic treatment.
  • Monitoring occurred every six months for metabolic (lipids, BMI) and neurologic complications.
  • The primary treatment involved atypical antipsychotics.

Main Results:

  • 45% of children developed lipid abnormalities, with significantly higher levels in boys and lower HDL in girls compared to population norms.
  • 49% had abnormal BMI percentiles, and abnormal BMI was strongly associated with lipid abnormalities (OR 6.0).
  • Neurologic complications occurred in only 3 children.

Conclusions:

  • Metabolic complications, particularly lipid abnormalities and abnormal BMI, are common in children with Tourette syndrome treated with antipsychotics.
  • Routine monitoring of growth and lipid profiles is essential.
  • Atypical antipsychotics appear to be associated with a low incidence of neurologic complications.

Related Concept Videos

Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...